A family of DNA sequences guiding gene editing in bacteria and beyond.
Researchers have used CRISPR to edit dogs’ genes, producing two hypoallergenic beagles. The dogs’ saliva and fur no longer carry the allergy-causing protein, offering hope to millions with dog allergies. Commercial availability remains years away as health, ethical, and adoption considerations are debated.
Anthropic has expanded its biology lab in San Francisco and bought Coefficient Bio to explore AI-assisted biotech. Leaders say real-life lab work is essential to testing AI-driven theories, while the company faces pushback from customers and industry observers over potential competition and safety concerns.
OpenAI has published AI-generated proofs that it says solve long-standing problems in mathematics, computer science and physics. The releases have prompted fierce debate: some researchers praise rapid progress; leading mathematicians including Terence Tao warn that AI-driven solutions risk erasing training pathways and require careful human verification. Scientific groups are organising reviews.
OpenAI will integrate Orchestra's team and tech into Rosalind, expanding life-science capabilities; Warp Sciences raises funding to automate wet-lab work and reshore drug development; Orchestra’s acquisition signals AI’s deepening role in pharma, as rivals compete for science-focused platforms.